What does the TOURMALINE-MM2 study tell us about the use of ixazomib in multiple myeloma?
Treatment landscape for elderly acute myeloid leukemia (AML) patients
What types of post-transplant complications does the biobank project aim to improve?
Regis Peffault de Latour
Smouldering myeloma: detection, risk stratification and defining a new standard of care
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian